Skip to menu Skip to content Skip to footer

2016

Journal Article

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

Chen, A. C., Martin, A. J., Dalziell, R. A., McKenzie, C. A., Lowe, P. M., Eris, J. M., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Bielski, V. A., Halliday, G. M. and Damian, D. L. (2016). A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology, 175 (5), 1073-1075. doi: 10.1111/bjd.14662

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

2015

Journal Article

BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301)

Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Chalasani, Venu, Long, Anne, Martin, Andrew, Sengupta, Shomik and Davis, Ian D. (2015). BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301). BMC Cancer, 15 (1) 432. doi: 10.1186/s12885-015-1431-6

BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301)

2015

Conference Publication

RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304)

Davis, Ian, Stockler, Martin, Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Dazo, Carlo, Long, Anne, Lawrence, Nicky, Chan, Howard, McDermott, Ray, Chowdhury, Simon, Marchesin, Vittorio, Deignan, Olwyn, Parulekar, Wendy, Suris, Alexander Montenegro and Sweeney, Christopher (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304). HOBOKEN: WILEY-BLACKWELL.

RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304)

2015

Conference Publication

RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301)

Chalasani, Venu, Sengupta, Shomik, Stockler, Martin, McCombie, Steve, Hawks, Cynthia, Krieger, Laurence, Anderson, Paul, Grummet, Jeremy, Mitterdorfer, Andrew J., Bishop, Conrad, Beardsley, Emma, Martin, Andrew, Lawrence, Nicola, Wong, Nicole, Chan, Howard, Pysarenko, Mariya, Harper, Matthew, Patel, Manish, Hamid, Akil, Davis, Ian and Hayne, Dickon (2015). RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301). HOBOKEN: WILEY-BLACKWELL.

RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301)

2015

Journal Article

Benefit of treatment of latent tuberculosis infection in individual patients

Dobler, Claudia C., Martin, Andrew and Marks, Guy B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46 (5), 1397-1406. doi: 10.1183/13993003.00577-2015

Benefit of treatment of latent tuberculosis infection in individual patients

2015

Conference Publication

ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS

Martin, Andrew (2015). ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS. HOBOKEN: WILEY-BLACKWELL.

ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS

2015

Conference Publication

RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501

Grummet, Jeremy, Davis, Ian, Martin, Andrew, Buchan, Nicholas, Chalasani, Venu, Frydenberg, Mark, Hayne, Dickon, Lalak, Andre, Patel, Manish, Williams, Andrew, Woo, Henry, Lawrence, Nicola, Chan, Howard, Bishop, Claudia, Wong, Nicole, Coskinas, Xanthi and Stockler, Martin (2015). RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501. HOBOKEN: WILEY-BLACKWELL.

RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501

2015

Conference Publication

RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303)

Williams, Scott G., Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Long, Anne, Yip, Sonia, Tu, Emily, Chan, Howard, Lawrence, Nicky, McDermott, Ray, Hughes, Simon, Marchesin, Vittorio, Deignan, Olwyn and Nguyen, Paul L. (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303). HOBOKEN: WILEY-BLACKWELL.

RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303)

2015

Journal Article

A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention

Chen, Andrew C., Martin, Andrew J., Choy, Bonita, Fernandez-Penas, Pablo, Dalziell, Robyn A., McKenzie, Catriona A., Scolyer, Richard A., Dhillon, Haryana M., Vardy, Janette L., Kricker, Anne, George, Gayathri St., Chinniah, Niranthari, Halliday, Gary M. and Damian, Diona L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373 (17), 1618-1626. doi: 10.1056/NEJMoa1506197

A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention

2015

Conference Publication

Discussing and prescribing expensive unfunded anticancer drugs in Australia

Karikios, D., Mileshkin, L., Martin, A., Ferraro, D. and Stockler, M. (2015). Discussing and prescribing expensive unfunded anticancer drugs in Australia. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(16)30506-8

Discussing and prescribing expensive unfunded anticancer drugs in Australia

2015

Journal Article

Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

Duchesne, Gillian M., Grand, Mel, Kron, Tomas, Haworth, Annette, Corry, June, Jackson, Michael, Ng, Michael, Besuijen, Deidre, Carter, Hannah E., Martin, Andrew, Schofield, Deborah, Gebski, Val, Torony, Joan, Kovacev, Olga, Amin, Rowena and Burmeister, Bryan (2015). Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology, 59 (3), 363-370. doi: 10.1111/1754-9485.12255

Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

2015

Journal Article

EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma

Davis, Ian D., Long, A., Yip, S., Espinoza, D., Thompson, J. F., Kichenadasse, G., Harrison, M., Lowenthal, R. M., Pavlakis, N., Azad, A., Kannourakis, G., Steer, C., Goldstein, D., Shapiro, J., Harvie, R., Jovanovic, L., Hudson, A. L., Nelson, C. C., Stockler, M. R. and Martin, A. (2015). EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. Annals of Oncology, 26 (6), 1118-1123. doi: 10.1093/annonc/mdv078

EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma

2015

Conference Publication

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

2015

Journal Article

Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer

Murray, Sonya R., Murchie, Peter, Campbell, Neil, Walter, Fiona M., Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Martin, Andrew, Goodall, Stephen, Barnes, David J. and Emery, Jon D (2015). Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer. BMJ Open, 5 (5) e008046, 1-7. doi: 10.1136/bmjopen-2015-008046

Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer

2014

Journal Article

Physical activity and fitness in women with metastatic breast cancer

Yee, Jasmine, Davis, Glen M., Beith, Jane M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2014). Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship, 8 (4), 647-656. doi: 10.1007/s11764-014-0378-y

Physical activity and fitness in women with metastatic breast cancer

2014

Conference Publication

THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCER

Emery, Jon, Schofield, Penny, Jefford, Michael, King, Madeleine, Pirotta, Marie, Hayne, Dickon, Martin, Andrew, Trevena, Lyndal, Lim, Tee and Constable, Roger (2014). THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCER. HOBOKEN: WILEY-BLACKWELL.

THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCER

2014

Journal Article

Do women notice the impact of childbirth-related levator trauma on pelvic floor and sexual function? Results of an observational ultrasound study

Thibault-Gagnon, Stéphanie, Yusuf, Sara, Langer, Suzanne, Wong, Vivien, Shek, Ka Lai, Martin, Andrew and Dietz, Hans Peter (2014). Do women notice the impact of childbirth-related levator trauma on pelvic floor and sexual function? Results of an observational ultrasound study. International Urogynecology Journal, 25 (10), 1389-1398. doi: 10.1007/s00192-014-2331-z

Do women notice the impact of childbirth-related levator trauma on pelvic floor and sexual function? Results of an observational ultrasound study

2014

Journal Article

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed

Carter, Hannah E., Martin, Andrew, Schofield, Deborah, Duchesne, Gillian, Haworth, Annette, Hornby, Colin, Sidhom, Mark and Jackson, Michael (2014). A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology, 112 (2), 187-193. doi: 10.1016/j.radonc.2014.03.020

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed

2014

Journal Article

Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients

Phu, Amy L., Xu, Zheyu, Brakoulias, Vlasios, Mahant, Neil, Fung, Victor S.C., Moore, Gregory De, Martin, Andrew, Starcevic, Vladan and Krause, Martin (2014). Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. Journal of Clinical Neuroscience, 21 (1), 63-66. doi: 10.1016/j.jocn.2013.02.032

Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients

2014

Journal Article

Cystocele recurrence after anterior colporrhaphy with and without mesh use

Wong, Vivien, Shek, Ka Lai, Goh, Judith, Krause, Hannah, Martin, Andrew and Dietz, Hans Peter (2014). Cystocele recurrence after anterior colporrhaphy with and without mesh use. European Journal of Obstetrics and Gynecology and Reproductive Biology, 172 (1), 131-135. doi: 10.1016/j.ejogrb.2013.11.001

Cystocele recurrence after anterior colporrhaphy with and without mesh use